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ABSTRACT 
Infection is a leading cause of death worldwide in babies under one month of age who are 
more susceptible to sepsis due to immature host defenc  mechanisms. Usually, babies may 
become acutely unwell from infective pathogens due to specific differences in their 
respiratory and immune systems. However, with the Covid-19 virus, the focus of this paper, it 
appears that the neonatal population is not significantly affected in the same way as adults. 
That said, knowledge about this novel virus is rapidly emerging. Therefore, it is vital that 
neonatal nurses, midwives and other healthcare profssionals are adequately informed and 
educated about the potential impact on neonatal practice. This review paper draws upon key 
findings and themes from a selection of recent literature to provide an overview of current 
knowledge on Covid-19 and the implications for care within the neonatal field.  The 
discussion focuses on the nature of Covid-19, its pa hophysiology and transmission relevant 
to maternal and neonatal care. This is followed by implications for practice; namely, maternal 
issues, the importance of human breast milk, neonatal c re relating to parenting and specific 
management before a final review of the current World Health Organization guidance.  
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The emergence and transmission of new viral disease represents a major threat to worldwide 
public health, particularly high-impact animal viruses such as Covid-19 that have switched 
hosts and are able to be transmitted within human populations. Infection is a leading cause of 
death worldwide in babies under one month of age who are more susceptible to sepsis due to 
immature host defence mechanisms. Covid-19 is a respiratory infection, and under normal 
circumstances babies who acquire pathogens may become acutely unwell due to the 
anatomical differences in their immune and respiratory systems. However, in Covid-19, it 
appears that the naivete of the neonatal immune syst m may have afforded protection against 
the ‘cytokine storm’ experienced by adults and so the incidence in the neonatal population 
remains low (Knight et al. 2020).  
 
Nonetheless, due to rapidly emerging knowledge about this novel virus and the need to adapt 
care environments to prevent cross-infection in babies, parents and staff, it is vital that 
neonatal nurses, midwives and other healthcare profssionals are adequately informed and 
educated about important areas that will impact on the care of babies and families. This 
review paper provides an overview of the current knowledge on Covid-19 and the 
implications for maternal and neonatal nursing care. Firstly, a background to the pandemic 
will be given followed by a review of a selection of current literature from which key areas of 
interest are discussed. These areas of knowledge focus on the nature of Covid-19, related 
pathophysiology and transmission with specific application to maternal and neonatal care. 
Implications for practice comprise maternal issues, the importance of human breast milk, 
parental and neonatal care such as the impact on early att chment and neonatal management 
including the use of dexamethasone. Finally, the current World Health Organization (WHO) 




Covid-19. a clinical syndrome caused by the coronavirus (SARS-CoV-2) became a pandemic 
following an outbreak of viral pneumonitis, first identified in Wuhan, Hubei, China. The 
disease manifests with a spectrum of symptoms ranging from mild upper respiratory tract 
infection to severe pneumonitis, acute respiratory distress syndrome (ARDS) and death. 
Relatively few cases have occurred in children and neonates who seem to have a more 
favourable clinical course than other age groups (De Rose et al. 2020). While not initially 
identified as a population at risk, pregnant woman ay be more vulnerable to severe 
infection (Favre et al. 2020) and evidence from previous viral outbreaks suggests a higher 
risk of unfavourable maternal and neonatal outcomes in this population (Alfaraj et al. 2019). 
Moreover, the associated policies developed as a reult of the pandemic relating to social 
distancing and prevention of cross infection have led to important considerations specific to 
the field of maternal and neonatal health, and a necessity to consider unintended 
consequences  for both the mother and baby (Buekens et al. 2020).  
 
Countries are faced with a rapidly developing clinial situation. While more definitive 
evidence is required on short and long term maternal, fet l and neonatal outcomes (Kimberlin 
& Stagno 2020) to ascertain impact in the neonatal population, the number of confirmed 
cases of Covid-19 has increased globally. At this stage it is not possible to gauge an accurate 
account of the number of neonates infected by Covid-19. Many reports are case studies and 
anecdotal experiences. However, in one American study, infants had a much higher 
hospitalisation rate than any other child age group. Of 95 infants, 62 percent were 
hospitalized (CDC 2020). The outcomes of these babies are not currently known. This has 
necessitated the need for the global neonatal community to prepare for a potential impact, but 
also for the development of policies to protect neonates, parents and staff. Concern for the 
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vulnerable, high-risk neonatal population goes beyond vertical transmission with the 
acknowledgement of risk to both mothers and neonates who may acquire Covid-19 through 
close contact with those infected or carrying the virus (Wang et al. 2020a).   
 
Therefore, given such uncertainty, this virus must be aken seriously in view of the potential 
impact, not only on disease transmission itself but on he ramifications of social distancing 
policies on families and health professionals. Moreover, in the light of the current lack of 
literature on Covid-19 in midwifery and nursing fields, there is a need to address these 
significant issues that are faced globally and contribu e a neonatal nursing and midwifery 
perspective to the emerging body of evidence during this pandemic.  
 
AIMS AND OBJECTIVES 
The aim of this paper is to address the current and emerging literature, largely medical in 
nature, and draw on essential implications for midwifery and nursing practice relating to the 
mothers, families and neonates in our care. 
The key objectives of the paper are: 
• To collate and analyse key literature on the incidence and implications of Covid-19 
within maternal and neonatal care. 
• To draw on key themes from the literature to inform neonatal nursing practice. 
• To contribute a neonatal nursing perspective to the em rging body of literature in this 
unprecedented time of the Covid-19 pandemic.  
 
METHODOLOGY AND SEARCH STRATEGY 
An integrative review methodology was utilized for this paper as it enables a broad review 
and facilitates a comprehensive understanding of Nenatal Covid-19 infection in babies. The 
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literature was gathered using a framework outlined as Arksey and O’Malley’s (2005) 5 step 
framework, and more recently Levac et al’s. (2010) method of synthesising health evidence. 
Covid-19 has only been seen in 2019 and 2020. Therefor , relevant and recent literature was 
easily identified using the terms; 
• Covid-19 in babies / neonates AND outcomes (1670) 
• Covid-19 in pregnancy AND outcomes (8410) 
It is noteworthy that publishers (Elsevier; PubMed) have made their peer-reviewed 
publications regarding Covid-19 available in full-tex  for researchers. The search was then 





• Full text in English (many of the earlier publications report results of women and 
babies in China because this is where Covid-19 is bel eved to have started) 
• Pregnancy in women with Covid-19 and the disease process 
• Guidelines for women with suspected Covid-19 infection 
• Articles about possible intrauterine transmission 
• Articles about possible transmission during labour and delivery 
• Neonatal Covid-19 case reports 
• Caring for the neonate with Covid-19 
 
Other resources have been used to form the background such as the neonatal immune 
response and the developmental characteristics of the neonatal respiratory system. Updates 
from the World Health Organisation and the Centers for Disease Control (CDC) have been 
utilised to ensure that any recommendations comply with current best evidence and practice. 









THE NATURE OF CORONAVIRUS 
Coronaviruses are a large family of viruses that can cause a range of illnesses. These illnesses 
include the common cold, Middle East Respiratory Syndrome (MERS) and Severe Acute 
Respiratory Syndrome (SARS). Coronaviruses have been around for many years; therefore, 
humans have built an immunity to them (Parrish et al. 2008). This is demonstrated by a 
common cold generally not being severe. When a new strain of coronavirus is discovered, it 
is called a ‘novel' coronavirus because it is a newcoronavirus that has not been previously 
identified. (CDC, 2020). The International Committee on Taxonomy of Viruses (ICTV) 
formally named the virus that causes Covid-19, severe acute respiratory syndrome 
coronavirus 2 or SARS-CoV-2 due to its genetic similarity to the virus that caused the SARS 























Coronaviruses are not just present in humans; and animals have coronavirus-related illnesses. 
These viruses can mutate and be passed on to humans (Parri h et al. 2008), referred to as 
“zoonotic spillover” (Johnson et al. 2015). When this appens, the disease can be more 
severe because humans have not had to fight the illness before, with SARS and MERS as 
examples. What makes this situation even more problematic is the evidence by Johnson et al. 
(2015) that the animal to human spillover of a new virus signals diseases that have a high 
pandemic potential, because they are able to amplify by human-to-human transmission with 
spread on a global scale. 
 
The first reported cases of Covid-19 appeared to be pot ntially from an animal source. 
Subsequent cases however were because of person to person transmission (Wu et al., 2020) 
and the virus is now known to be extremely contagious, particularly where there is close 
contact between people (Liu et al. 2020a). From its original source, it rapidly spread to other 
countries due to this high transmission rate, and in February 2020, the World Health 
Organisation (WHO) officially named the coronavirus as Covid-19 (WHOb, WHOc, 2020; 
Karimi-Zarchi et al. 2020). A pandemic was subsequently confirmed.  
 
TRANSMISSION OF COVID-19 IN BABIES 
How Covid-19 is spread is also an important area of kn wledge about which the world is still 
learning, particularly in the field of maternal and eonatal care. It is evident that symptomatic 
people with coronavirus disease are the main disseminators, but there is also emerging 
evidence that asymptomatic patients should not be und restimated (Heneghan et al. 2020). 
The major transmission routes are droplet, contact and aerosol. Faecaloral transmission 
cannot be ignored, because the virus was detected in the faecal samples of patients in the 
United States and China (Zheng et al. 2020). Regarding maternal and neonatal health, the 
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evidence on maternal-infant vertical transmission is still unclear. Favre et al. (2020) 
suggested that pregnant women may be more susceptible to the virus and Alfaraj et al. (2019) 
analysed evidence from previous viral outbreaks; namely SARS-CoV and MERS-CoV and 
put forward a suggestion of a greater risk of adverse maternal and neonatal outcomes. 
Whether a pregnant woman with Covid-19 could pass the infection to her fetus or baby 
during pregnancy or delivery is unknown. To date, emerging evidence to support vertical 
transmission of Covid-19 during pregnancy remains low (Knight et al. 2020) and according 
to existing data, amniotic fluid, cord blood, neonatal throat swab, placental tissue and 
breastmilk samples show low incidence (Yang et al. 2020a, 2020b). One study tested samples 
for SARSCoV2 from six newborn babies delivered to infected mothers; all samples tested 
negative for the virus (Lu & Shi 2020). 
 
PATHOPHYSIOLOGY OF COVID-19 IN BABIES 
The pathophysiology of the virus and how it affects the human body is now starting to be 
known. Covid-19 virus appears to directly infect cells via the ACE2 Receptor (Sriram et al. 
2020). This is expressed in various organs, including the lung. Cells in children’s lungs 
express this receptor less than those in adult lungs. This may be one reason why the infection 
affects children less severely.  
 
In relation to neonates specifically, much of the research has identified the immune and 
respiratory systems in neonates because they are considered to be immature in newborns. The 
respiratory physiology in neonates is different from that of older children and adults (Saikia 
& Mahanta 2019), and it is those differences that are responsible for why neonates can 
become acutely ill when they have a respiratory illness. Neonates are preferential nose 
breathers; however, their nasal passages are small and prone to be easily obstructed by thick 
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secretions, causing difficulty in breathing and an increase in the work of ventilation. The 
small diameter of the airways causes higher resistance to airflow in both term and preterm 
neonates. Neonates, especially premature ones, have fewer alveoli. The alveoli they possess 
lacks interalveolar communications and are at risk of collapse and atelectasis in dependent 
areas of the lung (Saikia & Mahanta, 2019; Neumann & von UngernSternberg, 2014; 
Mercer & Skovgaard, 2002).  
 
In neonates, the intercostal muscles are poorly developed and lack the ability to be the 
accessory muscles of respiration. The unfavourable ri  configuration of ribs being 
horizontally aligned from the vertebral column, means that the size of the thorax cannot be 
increased during inspiration. The diaphragm is respon ible for the workload of breathing in 
neonates; however, it is prone to be easily fatigued. To maintain minute volume, babies 
breathe faster with smaller tidal volumes (Saikia & Mahanta 2019; Mercer & Skovgaard 
2002).  
 
Neonates have low total lung capacity and functional residual capacity.  They have a highly 
compliant thoracic wall and poorly compliant lung tissue, which causes air trapping in the 
alveoli. Neonates attempt to modify the airflow to the small airways by creating a positive 
end inspiratory pressure (Saikia & Mahanta 2019; Neumann & von UngernSternberg 
2014). Neonates have higher basal metabolic requirement of oxygen, and this requirement 
increases when the baby is sick. 
 
The immune system is relatively immature at birth and neonatal mortality can be high when 
exposed to pathogens. During fetal life the development of the immune system is initiated by 
a highly complex process mediated by the expression of cytokines. Fetal cytokines play a role 
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to protect the fetus against rejection, and placental and fetal cytokines also protect against 
infection (Erić 2019). The transplacental transferal of maternal atibodies contributes to the 
early defence against pathogens, however this passive protection lasts until the child is six 
months of age (Basha et al. 2014).  
 
Newborns do not have fully developed innate or adaptive immune responses (Strauss-Albee 
et al. 2015). The innate immune system provides the first line of defence against invading 
pathogens in neonates. The cells in the innate immune system include neutrophils, 
monocytes, macrophages and dendritic cells, however the functions of all of the components 
of innate immunity are weak in newborns (Simon et al. 2015). Despite being mature, neonatal 
neutrophils show weak bactericidal functions, poor responses to inflammatory stimuli, 
reduced adhesion to endothelial cells and diminished chemotaxis (Nussbaum et al. 2013). 
Coupled with immaturity of monocytes and macrophages, impairment in neutrophil functions 
puts the baby at risk of significant viral infection. 
 
The adaptive immunity in the newborn consists of B cell lymphocytes and T cell 
lymphocytes (Basha et al. 2014). Both B and T cell lymphocytes originate in the bone 
marrow, however only B lymphocytes mature in the bone marrow. T lymphocytes migrate to 
the thymus for maturation. Following maturation both types of lymphocytes enter the 
bloodstream and migrate to peripheral lymphoid organs (Basha et al. 2014).One of the major 
roles that B cells play in an immune response is the production of antibodies, that specifically 
recognise and bind to proteins on the invading bacteria or virus particles (Basha et al. 2014).  
However, neonatal B-cells are naïve, lack specific antigenic exposure and have only a 
partially developed surface immunoglobulin (Ig) repertoire (Basha et al. 2014).  
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The three independent pathways that activate the complement system in the newborn are 
critical to host defence and inflammation. Complement components facilitate opsonization, 
are chemo-attractants for innate cells, mediate cell lysis and influence antibody production 
(Merle et al. 2015). Almost all of the concentrations of circulating immune components are 
10–80% lower than in adults. Complement levels increase after birth, with some serum 
factors reaching adult concentration within a month, however others evolve more slowly 
(Merle et al. 2015). Newborns have low immunoglobulin concentration, making the newborn, 
and particularly the premature baby, susceptible to bacterial and viral infections (Simon et al. 
2015). 
 
In neonates, the secretion of inflammatory mediators is deficient (Erić, 2019). Inflammation 
is a protective response to infection or injury, and the inflammatory response is controlled 
primarily by cytokines. Cytokines are endogenous mediators of the immune system and are 
directly involved in the activation of cells at the inflammatory site (Erić, 2019). It has been 
proposed that the balance of proinflammatory and anti-inflammatory cytokines may 
ultimately determine the outcome with sepsis in newborn infants (Machado et al. 2014). This 
inflammatory response may have its origins during the fetal period.  
 
One proposed disease mechanism in severe cases is a ‘cytokine storm’. This describes a 
cascade process whereby the immune system over-reacts to an infection. In Covid-19 the 
virus leads to an overproduction of immune cells and their activating compounds, cytokines, 
that are associated with a surge of activated immune cells into the lungs (Jose & Manuel, 
2020). The resulting lung inflammation (alveolar macrophage activation) causes direct tissue 
damage, recruitment of neutrophils to tissues, and other pro-inflammatory effects. This 
damage can lead to ARDS (Mehta et al. 2020). It is noteworthy that the cytokine storm is 
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particularly relevant in new influenza variants such as the H1N1 "swine flu" and H5N1 "bird 
flu" of recent years (Saunders-Hastings & Krewski 2016) 
 
Not much is known about the link between the naïve newborn immune system and the 
decreased risk of a cytokine storm in Covid-19. Mature immune response encompasses the 
ability to produce inflammatory cytokines and to regulate those responses. Zhao et al. (2008) 
suggest neonates are profoundly reliant on the innate immune system; this inflammation may 
help improve their chances of clearing pathogens at the risk of excessive activation and death. 
A sufficient number of T cells could be vital for protecting neonates from the lethal 
inflammatory response of innate cells (Zhao et al. 2008).  
 
Natural killer (NK) cells are granular lymphocytes and a component of the adaptive immune 
system and are among the earliest cellular responders and defence against most viral 
infections (Strauss-Albee et al. 2017; Bashe et al. 2014). NK cells serve as a bridge between 
innate immunity and adaptive immunity and release a variety of cytokines (Lee & Lin 2013). 
It is noteworthy that severe acute respiratory infection with the influenza virus in neonates 
has shown a decrease in NK cells in the blood, and that the influenza virus directly infects the 
NK cells causing apoptosis (Lee & Lin 2013).  
 
Concern has been raised that a cytokine storm and hyperinflammation may increase the risk 
for poor neurodevelopmental outcomes in the neonate (Martins-Filho &Tanajura, 2019). 
There is growing evidence that infection during pregnancy and enhanced expression of 
cytokines are associated with an increased risk of autism spectrum disorder and schizophrenia 




IMPLICATIONS FOR PRACTICE 
MATERNAL ISSUES  
The immune system of a newborn is the product of the immune environment during 
pregnancy. While responding to allo-antigens, the maternal immune system must be tolerant 
to the fetus (Yu et al. 2018). The placental immune response for specific viruses and 
pathogens affects the outcome of the pregnant woman's susceptibility to, and severity of, 
certain infectious diseases (Simon et al. 2015). 
 
Current evidence suggests that pregnant women are not at greater risk then other adults for 
contracting Covid-19 (Rasmussen et al. 2020). This is despite the fact that pregnant women 
are more susceptible to respiratory illness due to the physiological changes to the immune 
and cardiopulmonary systems that occur during pregnancy (Yan et al. 2020). Covid-19 
infection is not thought to be more severe in pregnant women despite the pre-existing 
physiological factors that predispose the women to more poorer outcomes during respiratory 
infections, that is, basal atelectasis from gravid uterus, lower lung reserves and increased 
oxygen consumption (Qiao 2020; Zaigham & Andersson 2020). Mostly reported, however, 
short intervals of time from diagnosis to caesarean deliveries (Chen et al. 2020). Therefore, 
the true impact has not been determined. Evaluation of 147 pregnant women reported up to 
8% severely ill and 1% critically ill which was less than that observed during the H1N1 
pandemic (Ashokka et al., 2020). Current evidence with pregnant women with Covid-19 
pneumonia indicate that conditions are similar to non-pregnant adults (Chen et al. 2020; Yan 
et al. 2020). There was insufficient data, however it indicated pre-eclampsia rate of 16%, and 
fetal growth restriction rate of 12%, which suggested fetal growth surveillance is needed after 




There is concern about the spread of infection during labour and birth because of the 
possibility of droplet contamination when women areforcefully exhaling during active 
labour. It been suggested there is a need to consider early epidural analgesia, and that 
unmedicated natural labour be discouraged (Ashokka et al. 2020). Infection control 
precautions includes restrictions on number of people in the room to minimise movement 
between care locations, and the number of external visitors and care providers (Ashokka et al. 
2020). This resulted in women not having partner or support people with them during labour. 
 
The caesarean section rate is reported to be high 86-100% (Della Gatta et al. 2020; Di Mascio 
et al. 2020; Yan et al. 2020; Zaigham & Andersson, 2020); the reason for this uncertainty is 
the risk of intrapartum vertical transmission considered early on in the history of pandemic 
(Chen et al. 2020). Indications are not well reported and have included the possibility of 
COVID-19 pneumonia (Della Gatta et al. 2020; Yan et al. 2020), fetal distress (Zaigham & 
Andersson 2020), as well as anxiety toward potential consequences of new viral infection 
(Della Gatta et al. 2020). There appears to be no risk of transmission during vaginal delivery 
as vaginal swabs of COVID-19 positive women are shown to be negative (Yan et al. 2020). It 
has been suggested that the threshold for caesarean delivery be lower than usual to ensure 
infection control procedures are adhered to. Based on evidence, COVID-19 infection cannot 
be considered as the indication for delivery and should be determined by individual factors 
such as worsening maternal health (Di Mascio et al. 2020; Ashokka et al., 2020). 
 
The number of premature births during Covid-19 has been documented between 42 to 56% 
(Di Mascio et al. 2020; Yan et al. 2020; Zaigham & Andersson 2020), however the risk of 
spontaneous miscarriage and spontaneous preterm birth do not appear to be increased (Yan et 
al. 2020). It would appear that the high preterm birth rate is related to the consequences of 
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elective intervention and are therefore iatrogenic i  nature (Di Mascio et al. 2020; Della Gatta 
et al. 2020; Yan et al. 2020). At this stage, the outc me of pregnant women with no or mild 
symptoms of Covid-19 infection is yet unknown  
 
To re-iterate, there is no evidence of vertical transmission when the infection manifests 
during the third trimester of Covid-19 positive pregnant women. Amniotic fluid and cord 
blood samples were found to be negative (Di Mascio et al. 2020; Yan et al. 2020), as were 
neonatal throat swabs and breastmilk samples (Chen et al. 2020). There has been reported, 
however, one case of suspected vertical transmission from Covid-19 positive women who 
had caesarean section and neonate separated from mother 10 minutes after birth found to be 
Covid-19 positive. It is believed therefore that vertical transmission cannot be excluded 
(Wang et al. 2020b). 
 
THE IMPORTANCE OF HUMAN BREAST MILK 
Human milk contains a variety of soluble and cellular antimicrobial substances which are 
believed to facilitate immune development and maturation in infants (Field 2005). Substances 
that modulate the inflammatory response have been identified in human milk and these could 
be beneficial to the newborn during Covid-19. A balance needs to exists between the 
protective inflammation and the modulation of inflammation that naturally exists in breast 
milk to protect the newborn against infection (Cacho & Lawrence, 2017). Human milk has 
both anti-inflammatory and pro-inflammatory cytokines, however anti-inflammatory 
cytokines dampens the T Helper cells’ 1 (Th1) cytokine response, thereby inhibiting pro-
inflammatory cytokine release (Cacho & Lawrence 2017; Field 2005). Osteoprotegerin, a 
member of the tumour necrosis factor (TNF) superfamily has been suggested to prevent TNF-
induced inhibition of T cell proliferation, thereby enabling T cells to dampen an 
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inflammatory response. Lactoferrin has been demonstrated to inhibit the production of 
proinflammatory cytokines (Field 2005). Epidermal growth Factor (EGF) also has anti-
inflammatory properties and is higher in preterm milk compared to full-term milk. 
   
PARENTAL ISSUES 
The impact of social distancing must not be under-estimated. When the pandemic took hold, 
neonatal units across the globe began to implement revised visiting policies to restrict the 
presence of parents and extended family, in an attemp  to protect hospitalised neonates. The 
policy was also introduced to minimise potential sickness in the number of healthcare 
professionals available to care for mothers and neonat s, should they need to self-isolate for a 
minimum of 7-14 days. The unfortunate consequence of such a policy has resulted in 
potentially long periods where parents are unable to see or touch their baby.  
Consequently, midwives and neonatal nurses around the globe are prevented in their ability to 
provide true family centred care. Given what we know about the impact of early separation 
on attachment between parent and baby and parental mental health (Petty et al. 2018; Fowler 
et al. 2019) and the practices that positively influence infant development and breastfeeding 
rates, such as skin-to-skin contact and family integrated care (O’Brien et al. 2018), the 
implementation of these are now more challenging. The concern is that preventing such 
beneficial strategies may therefore increase parentl stress, depression and anxiety due to 
parent-infant separation and being unable to participate in their baby’s care and develop their 
parenting role. Another concern is the potential disruption to communication with healthcare 
professionals, which is so essential (Gallagher et al. 2018). Midwives, neonatal nurses and 
health professionals have had to quickly adapt to this challenge and engage in the balancing 
act of providing optimum care to families whilst at the same time, ensuring the safety of all 
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neonates and parents under their care as well as their colleagues, their own families and the 
wider public. This is a situation that has not been faced in recent healthcare.  
 
NEONATAL COVID-19 AND MANAGEMENT 
The cases of neonatal COVID-19 have been limited to da e. It would appear neonates with 
COVID-19 have a mild course with favourable outcomes. Most recently, a review by 
Zimmermann and Curtis (June 2020) found no evidence for vertical transmission of SARS-
CoV or MERS-CoV. However, there was an association with complications such as IUGR, 
premature delivery. They also reported on two perinatal deaths, but it was unclear whether 
these were from SARS-CoV 2 or complications from caesarean delivery and prematurity.  
The most likely cause for the neonate becoming Covid-19 positive is through vertical 
transmission from the mother. Understandably, many of the initial reports have come from 
China (Luo & Yin, 2020; Li et al. 2020; Yang et al. 2020b; Liu et.al. 2020b; Yan et al. 2020). 
There is only a relatively small number of cases of neonatal COVI-19 and each study 
presents limited evidence of vertical transmission. In fact, the recent WHO (2020d) 
guidelines (as of June 25th, 2020) state there has been no confirmed mother-to-child 
transmission (WHO clinical management in Covid-19 interim guidance). Despite this, there 
are studies emerging where the findings leave this open to further interpretation.  
 
The evidence is equivocal. For example, a recent systematic review by Smith et al. (2020) 
found one case of neonatal Covid-19. However, evidence of vertical transmission is still 
unclear. Zaigham and Andersson’s (2020) systematic rev ew concluded that vertical 
transmission of the Covid-19 cannot be ruled out for neonatal infection. There was a case in 
Iran where a Covid-19 positive mother delivered a LGA at 32 weeks. The neonate had a 
positive nasal swab at 24 hours. All PCR tests were n gative for Covid-19 apart for the 
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amniotic fluid. The neonate had initial fever but was well. All precautions for droplet 
infection were undertaken and only the amniotic fluid was positive, the authors concluded 
that the neonate developed the infection in-utero (Zamaniyan et al. 2020). 
 
A recent French case study further questions the vertical transmission hypothesis. Abasse and 
colleagues (2020) describe a 33-week male neonate with a positive NP swab at 24 hours of 
age for SARS-CoV-2 who developed early mild respiratory distress. He was successfully 
managed with NIV for 24 hours and CPAP 48 hours. CXR normal lung aeration without 
pneumonia. However, on day 7-14 some respiratory distress returned with fever. The neonate 
was again tested with NP swab SARS-Cov-2 positive. He was managed with high flow nasal 
canula for his respiratory distress. The authors concluded the preterm labour was due to 
Covid-19, as there were no other indications for the preterm delivery. They also suggested a 
vertical transmission of Covid-19 could not be excluded as the baby was continually nursed 
in isolation with droplet and contact precautions (Abasse et al., 2020). 
 
Community transmission acquisition has been recorded in the literature, but the course is 
usually mild. Dumpa et al. (2020) highlight a case of a 22-day old male infant presenting at a 
New York emergency department with fever, tachycardia and decreased oral intake. The 
neonate had an uncomplicated term vaginal delivery, and was exclusively breastfed. He was 
not in any acute distress, however given the risk of community-acquired Covid-19, he had 
investigated for sepsis and a nasopharyngeal swab was performed. As a precaution, the 
neonate was cared for in a negative pressure room with strict droplet infection control 
precautions. The nasopharyngeal swab returned positive the day after admission. There was 
no indication of bacterial infection and his condition was stable. He was discharged home 
after two days with advice for parents to self-quarantine at home and continue meticulous 
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hand hygiene, particularly with feeding and nappy changes. The neonate continued to be well 
and thriving at the four-week follow-up appointment. 
 
Chacón-Aguilar et al. (2020) also discuss a presentatio  to a Spanish Emergency department 
of a 26-day old male neonate with fever and neurological manifestations. The neonate had 
been living in close contact with multiple symptomatic family members with Covid-19. He 
had a history of two episodes of seizure activity and on presentation had a fever with nasal 
discharge and vomiting. He had been exclusively breastf d since birth. Septic workup for 
bacterial infection was undertaken, as well as NP swab for Covid-19, which was positive. 
The neonate was admitted and isolated for droplet precautions in negative pressure room. The 
fever resolved after two days and there was no further seizure activity. Septic workup was 
negative for bacterial infection. He was hospitalised for six days with no further seizure 
activity. Neurological examination was normal, he was discharged home with isolation and 
hand hygiene for feeding and nappy changing (Chacón-Aguilar et al. 2020).  
 
Another concern for the transmission of a Covid-19 was through the breast milk of a positive 
mother and breast feeding was not advised. However, to date there has been no evidence of 
presence of virus in breastmilk of Covid-19 mothers and these mothers may continue to 
breastfeed using strict hand hygiene and droplet precautions (Velasco-Aro & Sanchez-
Mostiero, 2020).  
 
There was also some concern for a Covid-19 positive mother may infect the neonate in the 
postnatal period, and it was advised to separate and isolate mothers from their babies. This 
also been shown to be unnecessary (Stuebe, 2020). Lowe and Bopp (2020) describe a case in 
Queensland of a 40+2  week uncomplicated vaginal birth, Covid-19 positive mother who 
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roomed in with her Covid-19 negative neonate after birth. Both parents tested positive for the 
virus. As the neonate was well and breast feeding, no further Covid testing was indicated. 
The neonate continued rooming in with his/her parents a d was discharged on day four 
following birth.  The parents were advised to continue home isolation and use viral droplet 
precautions. The follow-up indicated the neonate was healthy and thriving (Lowe & Bopp, 
2020). 
 
The WHO (2020d) has concluded that Covid-19 mothers and their babies should not be 
separated, and skin-to-skin contact and breastfeeding encouraged, because the benefits 
outweigh any potential risks. WHO (2020d) recommend careful monitoring of pregnancies 
with COVID-19 with measures to prevent neonatal infection. Most common investigations 
include amniotic fluid, cord blood, placental swabs, genital swabs, with neonatal throat and 
nasopharyngeal swabs (Kallem & Sharma). Isolation with negative pressure rooms in NICU 
within a closed incubator is required only for symptomatic neonates (Zaigham & Andersson, 
2020).  
 
The studies so far suggest neonates can develop Covid-19, however, it is still not clear the 
route of transmission. It is therefore recommended that all newborns delivered from positive 
mothers are thoroughly investigated for the virus. If both mother and baby are well, there is 
no need to separate a positive mother from her baby. Likewise, if the mother and baby are 
well, skin-to-skin and breast feeding should be encouraged, as the benefits outweigh any 
potential harms. If a neonate becomes unwell and requir s intensive care, they should be 
nursed with droplet precautions in a closed incubator in a negative pressure room. The 
management is dictated by the presenting signs and symptoms. It would appear the presenting 
symptoms in the neonate are mild, with low-grade fev r and gastrointestinal signs such as 
21 
 
poor feeding and vomiting. The respiratory symptoms are also limited to mild tachypnoea 
and/or tachycardia. However, as there has been a presentation of seizure activity with fever a 
neurological examination should be part of the investigations. 
 
TREATMENT WITH DEXAMETHASONE  
As of writing this paper, there has been a preliminary study published in the general media 
from the University of Oxford on the use of dexamethasone in COVI-19 infections.  The 
RECOVERY (Randomised Evaluation of Covid-19 thERapY) trial enrolled over 11,500 
patients in a randomised controlled trial (RCT) in over 175 NHS hospitals in the UK. The 
trial randomised 2104 patient to receive dexamethasone 6mg in one daily dose for ten days 
and compared that with 4321 patients who received usual care. The study results showed the 
dexamethasone had significantly reduced mortality by one-third in ventilated patients and by 




Although the findings from this study have not been published in any peer reviewed paper, 
the consensus globally among the medical profession i  that this research group have a 
scrupulous research reputation and would not publish to the wider public if they were not 
confident of these results. Given these findings, the national medical director for the NHS and 
the chief medical officers of Wales, Scotland, Northe n Ireland, and England published a 
Therapeutic Alert on June 16th 2020 recommending an immediate change of practice. 
‘’Normally we would advise waiting for the full paper before changing practice, to 
ensure final analysis and peer review do not lead to ifferent conclusions. However, 
given this clear mortality advantage, with good significance, and with a well-known 
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medicine which is safe under these circumstances we consider it is reasonable for 
practice to change in advance of the final paper’’ 
 
The WHO has also welcomed these preliminary results and state it is “looking forward to a 
full data analysis” (https://www.who.int/news-room/detail/16-06-2020-who-welcomes-
preliminary-results-about-dexamethasone-use-in-treating-critically-ill-Covid-19-patients) 
Dexamethasone is a steroid used in many respiratory conditions associated with the 
inflammatory response. It is effective in suppressing the cytokine storm, which is the key 
factor in the severity of Covid-19 infections. Dexamethasone is also given to the mother in 
preterm labour to help mature the lungs and lessens the incidence of Respiratory Distress 
Syndrome in the premature neonate. To date, there hav  been no studies on the antenatal 
dexamethasone and severity of Covid-19 in the preterm neonate, however the results from the 
RECOVERY trial do raise the question of whether this could be beneficial in neonatal Covid-
19 infections (University of Oxford 2020). 
 
It is important to acknowledge that the current studies have focused on babies exposed in 
late pregnancy and the postnatal period. At this stage, there is no research that has explored 
whether there are any effects with exposure in early pregnancy, and whether Covid-19 is 
indeed teratogenic. It is recommended that future studies investigate this possibility.  
 
An interesting and positive outcome of the Covid-19 virus has been reported from Ireland as 
an unprecedented fall in preterm births from University Hospital, Limerick. There has been a 
73 percent reduction in the number of very low birth-weight babies born in the hospital, when 
compared to the average for the same first four months of the year in the preceding two 
decades. The reduction has been credited to the effect of positive lifestyle influences during 
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isolation and Covid-19 restrictions, and reduced exposure to ordinary stressors (Cullen 2020). 
The stressors that were reduced include work, commuting, increased family support, better 
infection avoidance, improved sleep, nutrition and exercise, and reduced exposure to tobacco 
and illegal drugs (Cullen, 2020). 
 
THE WORLD HEALTH ORGANISATION RECOMMENDATIONS 
The World Health Organisation Health Emergencies programme has an essential role to play 
in providing contemporary data in pandemics from the initial prevention to helping countries 
recover (https://www.who.int/emergencies/en/).  While neonatal clinicians and researchers 
publish their experiences in countries with Covid-19, the WHO experts have been collating 
data from countries and are providing guidance for countries on best practice and evidence 
during Covid-19 using a traffic light system with green, red and yellow symbols. Green 
denotes data, which is recommended and based on the best vidence, red practices which are 
not recommended and yellow, practices which are conditi ally recommended (WHO, 
2020d: Clinical management of COVID-19 – interim guidance 27th May 2020). 
 
The pertinent recommendations for countries for mothers who are Covid-19 positive and their 
babies are that the mother should not be separated from her baby, and breastfeeding should be 
encouraged as well as implementing increased hygiene practices. Specific recommendations 
on breastfeeding resulted from analysis of seventeen studies reporting the outcomes for 115 
positive mothers which found of 13 Covid-19 positive babies only four were breastfed and a 
further two mix-fed. Thus, with low potential transmission, the health benefits of 
breastfeeding outweigh the risks and the WHO recommends the initiation and continuation of 




Maternal and newborn health is not just directly impacted by illness in the mother or baby, 
the indirect costs through the impact on services could be substantial (Robertson et al. 2020). 
Riley et al. (2020) predict that with only a 10% decline in maternal and newborn care, an 
estimated 28,000 maternal and 16,800 newborn deaths could result, and with the disruption to 
family planning services, there could be many more unplanned pregnancies. Therefore, one 
of the key objectives for the WHO is to provide guidance to minimize the health systems 
impact of this pandemic across the lifespan.    
 
CONCLUSION 
The Covid-19 pandemic has presented neonatal nurses and midwives with challenges when 
caring for mother and babies. This review has present d what is currently known about 
Covid-19 and neonatal health, and information and research as they are generated will add to 
a complete picture of the health outcomes. While babies have been infected, the naivete of 
the neonatal immune system in relation to the inflammatory response would appear to be 
protective, with further inflammatory responses achieved with the consumption of human 
milk. The WHO has made clear recommendations about the benefits of breastfeeding, even if 
the mother and baby dyad is Covid-19 positive, if they remain well. The mother and baby 
should not be separated, and the mother needs to be able to participate in her baby’s care and 
develop her mothering role. The complexities of not being able to access her usual support 
people mean that the mother’s mental health should be a priority during isolation and social 
distancing.  
 
Understandably, the research related to neonatal Covid-19 infection is limited and in very 
early stages, and unfortunately much of the literature is vague and contradictory. For 
example, there is still no clear consensus on vertical transmission of the virus. Also, some 
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case studies suggest Covid-19 in the neonate is less severe but this requires much more robust 
research. Furthermore, future research needs to focus n maternal infection in early 
pregnancy and whether the virus is teratogenic. Finally, the most recent and promising 
research related to dexamethasone in reducing mortality, needs to be extended to antenatal 
dexamethasone use in preterm labour and the potential positive impact on neonatal Covid-19 
infection. 
 
Undoubtedly, more information, knowledge and research findings will emerge in this 
significant event in global healthcare. We will continue to learn, disseminate and share 
knowledge generated in the name of global, collabortive learning for the collective good of 
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